Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide versus risedronate for back pain in postmenopausal women with osteoporotic vertebral fractures
2005-005258-29Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Feb 2006
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of teriparatide, risedronate in osteoporosis, vertebral compression fracture (VCF), sponsored by Eli Lilly and Company. Started Feb 2006; status: completed.
02
Drugs
teriparatiderisedronate
03
Conditions
osteoporosisvertebral compression fracture (VCF)
Beyond the preview
Go deeper on 2005-005258-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005258-29.